Cutler Group LP Agios Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	SELL	$21.32 - $34.81 $19,188 - $31,329	-900 Reduced 17.65%	4,200 $14,000
Q3 2023 Nov 07, 2023	BUY	$24.36 - $28.18 $124,236 - $143,718	5,100 New	5,100 $36,000
Q4 2022 Feb 07, 2023	SELL	$24.81 - $31.52 $99,240 - $126,080	-4,000 Reduced 80.0%	1,000 $12,000
Q3 2022 Oct 25, 2022	BUY	$19.51 - $34.14 $19,510 - $34,140	1,000 Added 25.0%	5,000 $14,000
Q2 2022 Aug 04, 2022	BUY	$17.06 - $31.42 $64,827 - $119,396	3,800 Added 1900.0%	4,000 $6,000
Q1 2022 Apr 14, 2022	SELL	$26.68 - $34.81 $8,004 - $10,443	-300 Reduced 60.0%	200 $0
Q4 2020 Jan 21, 2021	SELL	$33.21 - $46.54 $83,025 - $116,350	-2,500 Reduced 83.33%	500 $0
Q2 2018 Aug 10, 2018	SELL	$73.22 - $99.55 $21,966 - $29,865	-300 Reduced 9.09%	3,000 $8,000
Q1 2018 May 11, 2018	BUY	$59.83 - $86.53 $53,847 - $77,877	900 Added 37.5%	3,300 $3,000
Q4 2017 Jan 17, 2018	SELL	$52.12 - $72.33 $943,372 - $1.31 Million	-18,100 Reduced 88.29%	2,400 $3,000
Q3 2017 Oct 17, 2017	BUY	$54.89 - $67.12 $1.13 Million - $1.38 Million	20,500	20,500 $22,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.